Antibody-mediated infection and cytotoxic T cells in cosackievirus B3 myocarditis
科萨基病毒 B3 心肌炎中抗体介导的感染和细胞毒性 T 细胞
基本信息
- 批准号:03670445
- 负责人:
- 金额:$ 1.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1991
- 资助国家:日本
- 起止时间:1991 至 1993
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Fc receptor (FcR)-mediated coxsackievirus B3 (CB3) infection in vitro and in vivo was investigated. When P388D1 cells (a murine macrophage-like cell line) were infected with CB3 exposed previously to various concentrations of anti-CB3 rabbit immunoglobulin G (Igg) or its Fab fragment, enhanced infection of CB3 was observed at a subneutralizing concentration of IgG, but not of Fab fragment. In addition, we confirmed the existence of this infectious pathway in vivo. C_3H/He mice with various levels of immunity by preinoculation of amyocarditic CB3 were reinoculated with myocarditic CB3. The severity of myocarditis and myocardial Cb3 titers were markedly enhanced in the mice with a low level of immunity compared to those with high or no immunity. Therefore, the insufficient immunity may not always provide a benign or protective influence. This immunological response facilitates the reinfection possibly inducing chronic active myocarditis.In addition, enterovirus-primed memory T cells would react similarly in vivo to a secondary inoculation with any cardiotropic enterovirus that shares an epitope(s) with the primary challenge virus. Thus, T cell-mediated immune responses to conserved antigenic epitopes among the enteroviruses was involved in the exacerbation of myocardial inflammatory disease during a second enterovirus infection. The secondary infection model may more accurately mirror virus-induced myocarditis in the human population because the majority of adults have exposed t several enteroviruses before induction of disease.
对Fc受体(FCR)介导的柯萨奇病毒B3(CB3)体内外感染进行了研究。用不同浓度的抗CB3兔免疫球蛋白G(Ig G)或其Fab片段感染小鼠巨噬细胞系P388D 1细胞时,在亚中和浓度的Ig G可增强Cb3的感染,而Fab片段则无此作用。此外,我们在体内证实了这种感染途径的存在。将预先接种肌源性CB3的不同免疫水平的C3H/He小鼠再接种心肌CB3。免疫水平低的小鼠与免疫水平高或无免疫水平的小鼠相比,心肌炎的严重程度和心肌CB3滴度显著增加。因此,免疫力不足并不总是提供良性或保护性的影响。这种免疫反应促进了再次感染,可能导致慢性活动性心肌炎。此外,肠道病毒免疫的记忆T细胞在体内对任何与初次挑战病毒具有相同表位(S)的嗜心肠道病毒的二次接种反应相似。因此,T细胞介导的对肠道病毒之间保守抗原表位的免疫反应参与了第二次肠道病毒感染期间心肌炎性疾病的加重。二次感染模型可能更准确地反映人类人群中病毒引起的心肌炎,因为大多数成年人在发病前接触过几种肠道病毒。
项目成果
期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Schnitt SJ,et al.: "Myocardial fibrin deposition in experimental viral myocarditis that progresses to diloted cardiomyopathy." Circ Res. 72. 914-920 (1993)
Schnitt SJ 等人:“实验性病毒性心肌炎中的心肌纤维蛋白沉积,进展为扩张型心肌病。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Schinitt S.T.: "Fibrin deposition in murne coxsackievirus B3 myocarditis." Circulation Research. (1993)
Schinitt S.T.:“鼠柯萨奇病毒 B3 心肌炎中的纤维蛋白沉积。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
岸本 千晴: "ウイルスの反復ないし重複感染が心筋障害におよぼす影響" CARDIAC PRACTICE. 3. 59-62 (1992)
Chiharu Kishimoto:“重复或叠加病毒感染对心肌损伤的影响”《心脏实践》3. 59-62 (1992)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kishimoto C, et al: "Cytokine and murine coxsackievirus B3 myocarditis" Circulation. (in press). (1994)
Kishimoto C 等人:“细胞因子和鼠科萨奇病毒 B3 心肌炎”循环。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kishimoto C, et al: "Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium" Cardiovasc Res. 27. 243-248 (1993)
Kishimoto C 等人:“洛苯扎利二钠增强小鼠柯萨奇病毒 B3 心肌炎”Cardiovasc Res。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KISHIMOTO Chiharu其他文献
KISHIMOTO Chiharu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KISHIMOTO Chiharu', 18)}}的其他基金
Myocardial regeneration by redox regulation in myocarditis with heart failure
心力衰竭心肌炎中氧化还原调节的心肌再生
- 批准号:
18590772 - 财政年份:2006
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Treatment for myocarditis with heart failure by the inhibitory Fc receptor of immunoglobulin
免疫球蛋白抑制性Fc受体治疗心肌炎心力衰竭
- 批准号:
14570656 - 财政年份:2002
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analyses of myocardial epitopes and apoptosis with treatment of peptide therapy in myocarditis.
心肌炎肽疗法治疗心肌表位和细胞凋亡的分析。
- 批准号:
09470164 - 财政年份:1997
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Myocardial damage by cultured autologous lymphocytes with IL-2 in viral myocarditis
IL-2培养自体淋巴细胞对病毒性心肌炎的心肌损伤
- 批准号:
06670702 - 财政年份:1994
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
The in Vivo Significance of T Cells in Coxsackievirus B3 Myocarditis
T 细胞在柯萨奇病毒 B3 心肌炎中的体内意义
- 批准号:
01570478 - 财政年份:1989
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Decoding Dilated Cardiomyopathy in vitro: Linking Genetic Mutations to Phenotypic Dysfunction
体外解码扩张型心肌病:将基因突变与表型功能障碍联系起来
- 批准号:
495567 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Miscellaneous Programs
Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families (DCM Next)
促进扩张型心肌病患者和家庭的诊断、患者分层和治疗取得进展 (DCM Next)
- 批准号:
10085929 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
EU-Funded
Evaluating sex specific differences in dilated cardiomyopathy
评估扩张型心肌病的性别特异性差异
- 批准号:
MR/W023830/1 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Fellowship
Using miRNA to identify new therapeutic pathways for dilated cardiomyopathy
使用 miRNA 确定扩张型心肌病的新治疗途径
- 批准号:
10740082 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Dysregulated mechanosignaling in dilated cardiomyopathy caused by defective Filamin C
Filamin C 缺陷引起的扩张型心肌病的机械信号失调
- 批准号:
10877387 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Development of strategies to enhance titin (TTN) expression and treat dilated cardiomyopathy caused by TTN haploinsufficiency
开发增强肌联蛋白 (TTN) 表达并治疗 TTN 单倍体不足引起的扩张型心肌病的策略
- 批准号:
10662742 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Elucidation of pathogenesis mechanisms and exploration of therapeutic strategies using mouse models of dilated cardiomyopathy
扩张型心肌病小鼠模型阐明发病机制并探索治疗策略
- 批准号:
23K18221 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Discovery and Characterization of Rare Variant Effects in Dilated Cardiomyopathy via Large-Scale Biobank Analysis
通过大规模生物库分析发现和表征扩张型心肌病的罕见变异效应
- 批准号:
10682290 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Elucidation of Molecular Basis for Myocardial Fibrosis in Dilated Cardiomyopathy
扩张型心肌病心肌纤维化的分子基础阐明
- 批准号:
23K15174 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists